The lymphoproliferation (lpr) mutation causes the defective expression
of Fas Ag, which normally transduces an apoptotic signal into cells,
T cells from mice homozygous for this mutation overexpress the counter
-receptor, Fas ligand. In this study, we investigated the effects and
regulatory influences attributable to Fas ligand overexpression on lym
phocyte development to clarify the role of Fas system-mediated apoptos
is in lymphopoiesis in vivo. Nonirradiated severe combined immunodefic
ient (SCID) mice grafted with a fetal thymus (FT) plus fetal liver cel
ls (FLC) from MRL-lpr/lpr mite (Fas Ag-defective mice), or with FT fro
m C3H-gld/gld mice (Fas ligand-defective mice) plus FLC from C3H +/+ m
ice, developed FLC-derived T and B cells. In contrast, SCID mice graft
ed with FT from MRL-lpr/lpr Thy-1.1 mice plus FLC from MRL +/+ Thy-1.2
mice (chimera 1) developed few FLC-derived T and B cells in the splee
n, and the thymus of the recipients also contained few FLC-derived T c
ells. In addition, when SCID mice grafted with FT from MRL-lpr/lpr Thy
-1.2 mice (H-2(k)) were co-transplanted with FLC from C57BL/10 Thy-1.1
mice (H-2(b)) (chimera 2), FLC-derived T and B cells developed normal
ly. Thy-1.1(+) cells from chimera 1 expressed Fas ligand mRNA about th
reefold higher than those from chimera 2, and seven- to eightfold high
er than Thy-1.2(+) cells from SCID mice grafted with FT from MRL +/+ T
hy-1.2 mice by Northern blot analysis. These findings indicate that ov
erexpression of Fas ligand on T cells significantly impairs both T and
B cell development. Furthermore, the Fas ligand overexpression suffic
ient to impair lymphopoiesis appears to require MHC-restricted T cell
activation. These results suggest that the Fas system suppresses lymph
opoiesis in vivo.